Metabolic syndrome criteria: ready for clinical prime time or work in progress?
Sattar
Naveed
N
Forouhi
Nita G
NG
D003327:Coronary Disease / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D024821:Metabolic Syndrome / Q000150:complications*; D017035:Pravastatin / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D017035:Pravastatin